RecruitingNot Applicable

Efficacy of Drug-Eluting Vertebral Artery Stenting Treatment for Atherosclerotic Vertebral Arteries Stenosis

China144 participantsStarted 2022-05-01

Plain-language summary

This is a prospective, multi-center, open-access, single-arm trial to observe the real-world clinical efficacy of drug-eluting vertebral artery stenting system treatment for Atherosclerotic Vertebral Arteries Stenosis. Patients will be followed at 30 days, 6, and 12 months post-procedure and annually for 1 year within 3 years.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age ≥ 18 years old, gender is not limited;
✓. Patients with medically prescribed rapamycin drug-eluting vertebral artery stent systems;
✓. Patients and family members fully understand the trial's purpose, voluntarily participate in the trial and sign the informed consent form.

Exclusion criteria

✕. Unable to receive dual antiplatelet therapy due to known disease, or severe coagulation abnormalities, severe infections that are not controlled, severe systemic disease, uncontrollable hypertension, and contraindicated for surgery;
✕. With an aneurysm that cannot be treated earlier or simultaneously or is not suitable for surgery;
✕. Gastrointestinal disease with active bleeding;
✕. Previous myocardial infarction or large-scale cerebral infarction within 2 weeks;
✕. Known contraindications to heparin, rapamycin, anesthesia, and contrast agents;
✕. Life expectancy less than 12 months;
✕. the investigator judged patients to be unsuitable for participation in this study.

What they're measuring

Incidence of clinical ischemic events

Timeframe: within 1 year

Trial details

NCT IDNCT05644314

SponsorNanfang Hospital, Southern Medical University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-05-31

Contact for this trial

Zhong Ji, PHD

020-62787664 jizhong22@hotmail.com

View on ClinicalTrials.gov More Ischemic Stroke trials